Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: MissLil who wrote (5065)	1/28/1998 7:31:00 AM
From: blankmind	Read Replies (3) \| Respond to of 23519

<<The first plant would have had to have been approved prior to the initial FDA approval>> - Are you sure? Can anyone else confirm this? -- Reason I ask: 1. Wasn't MUSE approved around 12/96? 2. And sales start immediately thereafter, around 1/97? 3. If so, then there was no 6 month delay from approval of MUSE to approval of plant - correct? 4. -- OR -- Are you saying the plant gets fda approval to produce in 6/96; and then 6 months later on 12/96, the MUSE drug was approved? 5. I'm just trying to figure out why Vivus is waiting on the FDA to approve the 2nd plant - instead of a product coming out of the 2nd plant. Out.